BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:RNA editing is emerging as a powerful tool and therapeutic mod ality\, with Wave Life Sciences announcing positive clinical data for AAT D\, and a new wave of companies entering the clinic\; the aspiration of b ringing efficacious editors to patients is ever closer to becoming a real ity. \;\n\nWith the forging of important partnerships like Roche and Ascidian\, and significant funding rounds like AIRNA's $155m oversubscrib ed series B\, the 6th RNA Editing Summit couldn't come at a better time\, returning to Boston this July to advance the discovery and development o f RNA modifying therapies.  \;\n\nUniting 60+ RNA editing leaders fro m the likes of Korro Bio\, Shape Therapeutics\, Deep Genomics\, HuidaGene Therapeutics\, and more\, this intimate\, focused forum will showcase no vel\, innovative editing technologies\, translational and functional biol ogy\, and never-before-seen clinical data.\n\nJoin your peers in Platform Biology\, Chemistry\, and R and D\, for an unrivaled learning and networ king opportunity to robustly accelerate more pre-clinical RNA editing can didates towards clinical development\, as we see the next wave of editors moving closer to patients in need. \;\n\nURLs:Brochure: \;https: //go.evvnt.com/3000511-0?pid=185Website: \;https://go.evvnt.com/30005 11-1?pid=185Tickets: \;https://go.evvnt.com/3000511-2?pid=185\n\nPric es:Conference + 2 Workshops (Drug Developer Pricing): USD 4197.00\,Confer ence + 1 Workshop (Drug Developer Pricing): USD 3598.00\,Conference Only (Drug Developer Pricing): USD 2999.00\,Conference + 2 Workshops (Academic Pricing): USD 3597.00\,Conference + 1 Workshop (Academic Pricing): USD 3 098.00\,Conference Only (Academic Pricing): USD 2599.00\,Conference + 2 W orkshops (Service Provider Pricing): USD 5097.00\,Conference + 1 Workshop (Service Provider Pricing): USD 4398.00\,Conference Only: USD 3699.00\n\ nSpeakers: \;Jacob Borrajo\, Founder and Chief Executive Officer\, Am ber Bio\, Steve Seedhouse\, Managing Director\, Biotech Equity Research\, Cantor Fitzgerald\, Keay Nakae\, Director of Research\, Chardan\, Tehmin a Masud\, Vice President and Head of Systems and Target Biology\, Deep Ge nomics\, TJ Cradick\, Chief Technology Officer\, HuidaGene Therapeutics\, Anna Dudkina\, Independent RNA Editing Expert\, Roger Song\, Senior Equi ty Research Analyst\, Jefferies\, Vincent DiGiacomo\, Director\, Therapeu tic Innovation\, Jorna Therapeutics\, Venkat Krishnamurthy\, Senior Vice President and Head of Platform\, Korro Bio\, Ram Aiyar\, Chief Executive Officer\, Korro Bio\, Gerard Platenburg\, Chief Scientific Officer\, ProQ R Therapeutics\, Andrew Fraley\, Chief Innovation Officer\, Radar Therape utics\, Robert Deans\, Chief Technology Officer\, Rett Syndrome Research Trust\, Yang Gao\, Assistant Professor\, Rice University\, Brian Booth\, Director Computational Biology RNAfix\, Shape Therapeutics\, Chad Weldy\, Instructor\, Cardiovascular Medicine\, Stanford University\, Peter Nell\ , Chief Execuitve Officer\, Stealth Biotech\, Peter Beal\, Professor\, Un iversity of Calfornia Davis\, Artem Nemudryi\, Assistant Professor\, Univ ersity of Florida\, Paul Bolno\, Chief Executive Officer\, Wave Life Scie nces\n\nCategory: \;Conferences | Science\, Health and Medicine | Pha rmaceuticals\n\nDate and Time: \;29th July 2025 at 8:00 am to 31st Ju ly 2025 at 4:15 pm\n\nVenue details: \;Wyndham Boston Beacon Hill\, 5 Blossom Street\, Boston\, Massachusetts\, 02114\, United States\n DTEND:20250731T161500 DTSTAMP:20260512T234009Z DTSTART:20250729T080000 LOCATION:Wyndham Boston Beacon Hill\, 5\, Blossom Street\, Boston\, Massac husetts\, 02114\, SEQUENCE:0 SUMMARY:RNA editing is emerging as a powerful tool and therapeutic modalit y\, with Wave Life Sciences announcing positive clinical data for AATD\, and a new... UID:605fc3bb-06fe-4082-ac53-046bd0f3dfdd END:VEVENT END:VCALENDAR